CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 59320-59557 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T341","span":{"begin":0,"end":237},"obj":"Sentence"},{"id":"T14538","span":{"begin":0,"end":237},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Eldebss and colleagues [131] prepared a series of pyrazolones acting as a-glucosidase and a-amylase inhibitors, among which compound 175 (Fig. 18) compound 176 (Fig. 18 ) displayed the strongest inhibitory effect with the ratio of 61.6%."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T55","span":{"begin":0,"end":237},"obj":"Sentence"}],"text":"Eldebss and colleagues [131] prepared a series of pyrazolones acting as a-glucosidase and a-amylase inhibitors, among which compound 175 (Fig. 18) compound 176 (Fig. 18 ) displayed the strongest inhibitory effect with the ratio of 61.6%."}